Nestlé Bets $525M On Seres Therapeutics Microbiome Drug For Infectious Diseases
Seres Therapeutics Inc (NASDAQ: MCRB) has inked a $525-million deal with Nestlé Health Science to commercialize SER-109 if it can win FDA approval. SER-109…
Benson Hill SPAC Deal: The ‘Thing Behind The Thing’ For Plant-Based Food Market
Benzinga routinely examines a stock that might be considered a little under the radar. The company may not be well known, but chances are the line of work it’s in is pretty familiar. This is called the “thing behind the thing.”
15 European Dividend Aristocrats To Diversify Your Portfolio
In general, Dividend Aristocrats are the foundation for the portfolios of most serious dividend growth investors. European Dividend aristocrats are typically blue chip stocks that have proven to reward shareholders with rising dividends over a long period.
KKR to Sell The Bountiful Company to Nestlé for $5.75B
KKR (NYSE: KKR) today announced that Nestlé (OTC: NSRGY) has agreed to acquire The Bountiful Company, a pure play branded leader in global nutrition, for $5.75 billion.
Nestle CEO Discusses Sustainability Program
Nestle (OTC:NSRGY) previously announced it will spend $2 billion to cut plastic waste and this could be seen as…